Structure-based drug designing and immunoinformatics approach for SARS-CoV-2

The article offers information about the structure-based drug designing and immunoinformatics approach for SARS-CoV-2. It discusses the prevalence of respiratory illness caused by the novel SARS-CoV-2 virus associated with multiple organ failures is spreading rapidly because of its contagious human-to-human transmission and inadequate global health care systems.